News

Latest report suggests a slower rate of growth and constrained capacity

Shipment from Basel, Switzerland, to JFK airport, New York, consisted of three Releye RAP units and two RAP e2 units.

Acquisition of data-driven prescription drug benefit and affordability company will ”help patients overcome financial barriers to starting and staying on therapy.”

New center comes in response to increasing demand for firm’s medicines

Acquires MarketShare Movers, as company aims to provide patients with affordability services

CDMO’s Chenôve facility receives investment from French government

Deal expected to help expand its API production services

Agreement establishes company’s first mRNA manufacturing facility in Africa

Healthcare market research and insights company will become part of Ashfield Advisory.

Expansion features 11 new cGMP labs at Durham, NC location

If given green light by European Commission, vaccine dose will be less than that of adolescents

GTS improvements include additional data integrity protection, greater Level 1 and 2 equipment compatibility

The latest people news happenings over the past month

New consortium provides integrated solution with specialist services, from biologics discovery to clinical and commercial manufacturing.

The parties are partnering up to leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies

Advance purchase agreement is for up to 200 million doses of Nuvaxovid

Discussions will revolve around fortifying the pharma supply chain

Turnkey centers will promote scalable vaccine production for an end-to-end manufacturing network for mRNA-based vaccines in Africa

CDMO obtains both Vibalogics and Arranta Bio to increase presence in the sector

Will establish presence in Belgium, Denmark, Norway, the Netherlands, Poland and Sweden

Plans are underway to build Scottish fill-finish center, renovate API facility in England

Agreement provides pharma firms with an RWD and commercialization solution

Publication finds that only about 40% of retail pharmacists feel equipped to discuss biosimilars with patients

The solution is a combination of cold chain logistics, serialization compliance and distribution

With the deal, the China-based CDMO grows its US presence

Quris’s system can help predict clinical safety, AI firm notes

Software firm merges with PharmaLex Group

Collaboration, the companies note, is expected to further engage patients